Edgewise Therapeutics Cash Flow Statement 2020-2024 | EWTX

Fifteen years of historical annual cash flow statements for Edgewise Therapeutics (EWTX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020
$-100.16$-67.64$-42.81$-17.12
$-7.79$-0.01$0.27$0.19
$17.56$10.92$4.40$0.35
$9.78$10.92$4.68$0.54
$0$0$0$0
$0$0$0$0
$-0.09$0.05$2.65$0.52
$-1.47$4.04$1.98$1.43
$-1.56$4.09$4.63$1.95
$-91.95$-52.64$-33.51$-14.63
$-5.75$-5.55$-0.67$-0.20
$0$0$0$0
$0$0$0$0
$0$0$0$0
$109$-65.03$-241.56$-24.18
$109$-65.03$-241.56$-24.18
$0$0$0$0
$103$-70.58$-242.23$-24.38
$0$0$0$0
$0$0$0$0
$0$0$0$0
$53.33$130$0.36$0.20
$53.33$130$0.36$120
$0$0$0$0
$-0.17$-0.25$186$0
$53.17$130$186$120
$64.10$6.43$-89.35$81.26
$17.56$10.92$4.40$0.35
$0$0$0$0